China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

XSEC:000999 Stock Report

Market Cap: CN¥57.9b

China Resources Sanjiu Medical & Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

China Resources Sanjiu Medical & Pharmaceutical has a total shareholder equity of CN¥26.1B and total debt of CN¥2.6B, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are CN¥40.8B and CN¥14.7B respectively. China Resources Sanjiu Medical & Pharmaceutical's EBIT is CN¥4.1B making its interest coverage ratio -106.9. It has cash and short-term investments of CN¥8.8B.

Key information

10.0%

Debt to equity ratio

CN¥2.61b

Debt

Interest coverage ratio-106.9x
CashCN¥8.85b
EquityCN¥26.06b
Total liabilitiesCN¥14.71b
Total assetsCN¥40.77b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 000999's short term assets (CN¥23.1B) exceed its short term liabilities (CN¥12.3B).

Long Term Liabilities: 000999's short term assets (CN¥23.1B) exceed its long term liabilities (CN¥2.4B).


Debt to Equity History and Analysis

Debt Level: 000999 has more cash than its total debt.

Reducing Debt: 000999's debt to equity ratio has increased from 0.2% to 10% over the past 5 years.

Debt Coverage: 000999's debt is well covered by operating cash flow (166.7%).

Interest Coverage: 000999 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies